| # | Side effect | Count |
|---|---|---|
| 0 | DEEP VEIN THROMBOSIS | 2 |
| 1 | ANHEDONIA | 1 |
| 2 | ANION GAP INCREASED | 1 |
| 3 | ANXIETY | 1 |
| 4 | CARDIAC OPERATION | 1 |
| 5 | COVID-19 | 1 |
| 6 | DISABILITY | 1 |
| 7 | GENERAL PHYSICAL CONDITION ABNORMAL | 1 |
| 8 | ILLNESS | 1 |
| 9 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 1 |
| 10 | INFLUENZA | 1 |
| 11 | INJURY | 1 |
| 12 | INSURANCE ISSUE | 1 |
| 13 | INTENTIONAL DOSE OMISSION | 1 |
| 14 | LACTIC ACIDOSIS | 1 |
| 15 | LOSS OF CONSCIOUSNESS | 1 |
| 16 | LOWER RESPIRATORY TRACT INFECTION | 1 |
| 17 | MENTAL DISORDER | 1 |
| 18 | NASOPHARYNGITIS | 1 |
| 19 | OSMOLAR GAP INCREASED | 1 |
| 20 | PAIN | 1 |
| 21 | PNEUMONIA | 1 |
| 22 | PRODUCT DOSE OMISSION ISSUE | 1 |
| 23 | PRODUCT USE ISSUE | 1 |
| 24 | PULMONARY EMBOLISM | 1 |
| 25 | SEPTIC SHOCK | 1 |
| 26 | SINUS TACHYCARDIA | 1 |
| 27 | SINUSITIS | 1 |
| 28 | SOMNAMBULISM | 1 |
| 29 | SUICIDE ATTEMPT | 1 |
| 30 | THROMBOPHLEBITIS SUPERFICIAL | 1 |
| 31 | TOXICITY TO VARIOUS AGENTS | 1 |